Barbell Medicine Podcast

Overtraining Syndrome: Causes, Diagnosis, and What's Actually Going On

In 2022, researchers conducted the most rigorous systematic review ever performed on overtraining syndrome — looking specifically for controlled studies that documented a human transitioning from a healthy training state to an overtrained state. Zero studies met those criteria. The word "overtrained" appears in coaching certifications, wearable device dashboards, and clinical sports medicine guidelines — and in each context it means something different. That definitional chaos has consequences: it delays real diagnoses, produces nocebo effects with measurable physiological outcomes, and leads athletes to reduce training they didn't need to reduce.In this episode, Drs. Jordan Feigenbaum and Austin Baraki work through the full evidence base on overtraining syndrome — the taxonomy, the attempted studies, the six competing mechanistic theories, the biomarker failures, and what's actually happening when a lifter can't make progress. Timestamps:0:00 Cold open — the zero-studies finding1:21 Why "overtrained" does four different jobs simultaneously16:10 The FOR / NFOR / OTS taxonomy19:43 The supercompensation model — borrowed from endurance, never validated for resistance training32:28 Austin's clinical differential for fatigue and declining performance36:17 RT evidence — what happens when researchers try to induce OTS through lifting43:19 Austin — what actually drives the complaints he sees in practice47:30 Six theories for what causes overtraining syndrome1:01:09 The biomarker problem — why the T:C ratio and cortisol don't work1:05:09 What your wearable is actually measuring (and what it isn't)1:09:28 Austin — testosterone levels in trained athletes and when to act1:13:40 Heart rate variability — limitations for strength training1:15:36 Session RPE — the monitoring tool that actually works1:17:31 How common is overtraining syndrome, really?1:23:04 Three failure modes — what's actually happening when lifters say they feel overtrained1:32:14 Austin — what a proper medical workup looks like1:34:22 OutroWhat we cover:The definition problem — why a single word is doing four incompatible jobs simultaneously, and why that matters clinically and practically.The taxonomy — functional overreaching, nonfunctional overreaching, and overtraining syndrome as points on a continuous variable that can only be identified after the fact, not at presentation.The supercompensation model — where it came from, why it fails to describe how resistance training adaptation actually works, and how applying it too literally produces both overloading and underloading errors at the same time.Austin's clinical differential — what a physician actually works through when a patient presents with fatigue and declining performance, and where overtraining syndrome actually sits on that list.What resistance training research shows — including 140 maximal singles, 90 working sets per week, and daily 1-rep max attempts. No study has cleanly induced overtraining syndrome through resistance training. The hormonal data went in the opposite direction from what the endurance overtraining model predicts.Six mechanistic theories — glycogen depletion, serotonin/BCAA, autonomic imbalance, central governor, HPA axis dysregulation, and Armstrong's complex systems framework. Each one is partially supported and each falls short.The biomarker problem — resting cortisol is normal in 75%+ of OTS cases, the testosterone to cortisol ratio has never been validated against clinical outcomes as an individual diagnostic, and HRV recovery in strength training lags physical recovery by up to 30 hours.Austin on wearables — including a clinical pattern he's seeing with GLP-1 receptor agonists: wearable scores indicating deterioration when the clinical picture is actually fine.Session RPE as the real tool — why session RPE trending upward at stable training load is a more reliable signal of load-recovery mismatch than any biomarker currently used.Prevalence and confounders — the 60% figure, why it almost certainly captures all three FOR/NFOR/OTS categories plus REDS, depression, and illness, and why the residual true training-load-induced OTS in an otherwise healthy athlete may be vanishingly rare.Three failure modes — the three things Jordan actually sees in practice when lifters present saying they feel overtrained, and how to distinguish between them using session RPE.The medical workup — Austin's practical walkthrough of what to assess when programming and lifestyle changes don't move the needle, including iron deficiency (ferritin testing caveats, lab reference range problems), sleep apnea, post-viral syndromes, and hormone panels done correctly.Next Steps:For evidence-based resistance training programs: barbellmedicine.com/training-programsFor individualized training consultation: barbellmedicine.com/coachingExplore our full library of articles on health and performance: barbellmedicine.com/resourcesTo consult with Drs. Baraki or Feigenbaum email us at support@barbellmedicine.comFor ad free listening and exclusive discounts, become a Barbell Medicine Plus subscriber at https://barbellmedicine.supercast.com/ Resources Taxonomy / DefinitionsMeeusen et al. (2013)European College of Sport Science / ACSM consensus statement on FOR, NFOR, and OTS taxonomy. Defines OTS as a diagnosis of exclusion.https://pubmed.ncbi.nlm.nih.gov/23247672/Meeusen et al. (2006)"Often only after a period of complete rest" — the retrospective nature of distinguishing NFOR from OTS.https://pubmed.ncbi.nlm.nih.gov/23016079/Nocebo Effects in Sport2024 Systematic ReviewNocebo effects in sport were approximately twice the magnitude of placebo effects on performance across 20 studies.https://pubmed.ncbi.nlm.nih.gov/38999724/Stress-Recovery-Adaptation ModelOriginal general adaptation syndrome / stress physiology work in Nature. Foundational source the SRA model was derived from — not a sports science paper.https://www.nature.com/articles/138032a0Multi-system adaptation timescales; critique of single-wave supercompensation model.https://pubmed.ncbi.nlm.nih.gov/3057313/Multi-system adaptation timescales; further critique of the SRA "window of opportunity" model.https://pubmed.ncbi.nlm.nih.gov/15044685/Lack of empirical support for the supercompensation "window of opportunity" in real training scenarios.https://pubmed.ncbi.nlm.nih.gov/29189930/Resistance Training and OTSGrandou et al. (2020)Systematic review: 22 studies on resistance training overtraining. 10 showed zero performance decline under deliberate overload. No reliable biomarker established for RT overtraining; sustained performance drop is the only consistent signal.https://pubmed.ncbi.nlm.nih.gov/31313309/Coleman et al. (2024)9-week supervised high-volume RT protocol (~90 sets/week). No OTS criteria met. Ceiling for resistance training-induced OTS is considerably higher than commonly implied.https://pmc.ncbi.nlm.nih.gov/articles/PMC10809978/Zourdos et al. (2016)Case series: 3 competitive strength athletes performed daily 1RM squat for 30 consecutive days. All three improved.https://pubmed.ncbi.nlm.nih.gov/26816276/Daily 1RM Bench Press Study7 athletes attempted a true 1RM bench press every day for 38 days. All improved despite day-to-day fluctuation.https://www.thefreelibrary.com/Efficacy+of+Daily+One-Repetition+Maximum+Bench+Press+Training+in...-a08283175013 weeks of daily loading; volume arm hypertrophied. Daily frequency did not produce overtraining; volume drives hypertrophy, not frequency alone.https://pubmed.ncbi.nlm.nih.gov/27875635/Fry et al. (1994) — Overreaching ProtocolOriginal resistance overreaching induction: 10×1 at 100% 1RM daily for 14 days. 1RM dropped ~12 kg. Hormonal response was opposite to endurance OTS profile (cortisol decreased, testosterone slightly increased).https://pubmed.ncbi.nlm.nih.gov/7808252/Fry et al. (1994) — Endurance BiomarkersEndurance OTS biomarkers (T:C ratio) do not apply to high-intensity resistance training overreaching.https://pubmed.ncbi.nlm.nih.gov/9843563/Fry et al. (2006)Same overreaching protocol with muscle biopsies. Beta-2 adrenergic receptor density in vastus lateralis decreased 37%. Orthopedic ceiling hypothesis: structural limits intervene before neuroendocrine axis fully desensitizes.https://pubmed.ncbi.nlm.nih.gov/16888042/Raastad et al. (2001)Daily submaximal leg training for 2 weeks; 1RM increased 6%. Intensity (not frequency) is the necessary ingredient for overreaching in resistance training.https://pubmed.ncbi.nlm.nih.gov/11394254/Margonis et al. (2007)12-week progressive RT peaking at ~14 tonnes/week. Significant 1RM decrements not restored after 6-week taper — the only resistance training study to approach true OTS criteria.https://pubmed.ncbi.nlm.nih.gov/17697935/HPA Axis / BiomarkersCadegiani & Kater (2017) — EROS StudyResting cortisol is normal in ≥75% of OTS studies. Reduced pituitary ACTH output (not adrenal failure) is the upstream dysregulation in OTS. "Adrenal fatigue" is mechanistically backwards.https://pmc.ncbi.nlm.nih.gov/articles/PMC5722782/EROS Study — Extended FindingsFurther EROS study data on HPA axis dysregulation patterns in OTS.https://pmc.ncbi.nlm.nih.gov/articles/PMC6590962/Testosterone: acute 30% drops occur routinely after a marathon and normalize within days. Never validated as an individual OTS diagnostic.https://pubmed.ncbi.nlm.nih.gov/3744643/Saw et al. (2016)56-study systematic review of athlete monitoring tools. Subjective measures (mood, perceived fatigue, sleep quality) tracked training load changes with greater sensitivity than objective markers including hormones, resting HR, and HRV.https://pmc.ncbi.nlm.nih.gov/articles/PMC4789708/Meeusen et al. (2004/2010) — Two-Bout Exercise ProtocolTwo maximal incremental tests 4 hours apart with serial blood draws. OTS athletes show blunted ACTH/prolactin response to second bout; NFOR athletes show exaggerated response. Most validated objective test available; not a field tool.https://pubmed.ncbi.nlm.nih.gov/18703548/HRV as a Monitoring ToolHRV for OTS detection: weak data, foundational work done in cyclists and triathletes only.https://pubmed.ncbi.nlm.nih.gov/23852425/Strength recovery occurred ~30 hours after heavy loading; HRV had not normalized at 60 hours. Using HRV as a daily training prescription tool in strength athletes is an untested assumption.https://pubmed.ncbi.nlm.nih.gov/21273908/Session RPE and MonitoringFoster et al. (1998)Session RPE method: training load quantified as RPE × session duration. Key monitoring metric throughout the episode.https://pubmed.ncbi.nlm.nih.gov/9662690/Soreness, mood, and motivation relative to training load as monitoring signals.https://pubmed.ncbi.nlm.nih.gov/38321325/PrevalenceMorgan et al. (1987)The commonly cited 60% OTS prevalence figure. Retrospective self-report using the term "staleness," conducted before the current taxonomy existed. Almost certainly captures all three tiers of the FOR/NFOR/OTS continuum.https://pubmed.ncbi.nlm.nih.gov/3676635/Confounders: PED UseAnonymous Survey Data (2011)29% of Track and Field World Championship athletes admitted PED use; 45% at Pan-Arab Games.https://core.ac.uk/download/pdf/109992897.pdfLippi et al. (2015)WADA detects PED use in only 1–2% of samples; USADA detection rate

Episode #391: VO2 Max vs. Cardiorespiratory Fitness, GLP-1 Costs, and the 10,000-Step Myth | Direct Line March 2026 (Free)

In this free preview of the March 2026 Direct Line AMA. Drs. Feigenbaum and Baraki cover: VO2 max versus cardiorespiratory fitness for longevity (are Peter Attia’s targets evidence-based? — with Goodhart’s Law and the JAMA evidence), what GLP-1 medications actually cost now via manufacturer programs ($149–449/month), and whether 7,000–10,000 daily steps actually meet the bar for cardiovascular training. Full episode for Barbell Medicine Plus subscribers at https://barbellmedicine.supercast.com/Timestamps:0:00 — Introduction3:26 — VO2 Max vs. Cardiorespiratory Fitness for Longevity14:11 — GLP-1 Costs: What you should actually be paying now21:43 — Is Walking Enough for Cardiovascular Health?Next Steps:For evidence-based resistance training programs: barbellmedicine.com/training-programsFor individualized training consultation: barbellmedicine.com/coachingExplore our full library of articles on health and performance: barbellmedicine.com/resourcesTo consult with Drs. Baraki or Feigenbaum email us at support@barbellmedicine.comResources: JAMA Network Open — Cardiorespiratory Fitness & Long-term Mortality (Mandsager et al.) — Exercise capacity (METs) and longevity — the foundational CRF/mortality study cited in the episode https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2707428JAMA — Blair et al. — Physical fitness and all-cause mortality: a prospective study of healthy men and women https://jamanetwork.com/journals/jama/fullarticle/379243Barbell Medicine Vital Five — Multi-modal CRF benchmarks and longevity targets https://www.barbellmedicine.com/vital-5-action-plan/Lilly Direct — Zepbound (tirzepatide) — Manufacturer direct program ($299–449/month) https://www.lillydirect.com/zepboundNovoCare — Wegovy (semaglutide) — Manufacturer savings program ($149–349/month) https://www.novocare.com/patient/medicines/wegovy.htmlOrforglipron — Eli Lilly oral GLP-1 — What to know about orforglipron (small-molecule oral GLP-1 agonist, pending FDA approval) https://www.lilly.com/news/stories/what-to-know-about-orforglipronOur Sponsors:* Check out Factor: https://factormeals.com/bbm50off* Check out Quince: https://quince.com/BBMAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode #390: Why Your Waist Matters More Than Your Weight — The Science of Visceral Fat

You can have a completely normal BMI and be on your way to cardiovascular disease, type 2 diabetes, and metabolic syndrome without triggering a single alert on a standard health screening. The fat that predicts metabolic risk most accurately isn't the fat your scale or your doctor is tracking. Dr. Jordan Feigenbaum breaks down the science of visceral fat — what it is, how it causes disease, how to measure it correctly at home for free, and what the evidence actually shows about exercise, GLP-1 medications, and testosterone.Timestamps:00:00:00 Cold Open: The Visceral Fat Finding00:00:49 The Scale Problem — What Body Weight Actually Measures 00:03:50 What Is Visceral Fat — and Why It's Not Just "Belly Fat"00:05:04 Three Competing Theories: How Visceral Fat Actually Causes Disease 00:08:35 Adipokines: PAI-1, Angiotensinogen, and What Happens When Adiponectin Drops 00:09:52 How to Measure: Three Sites That Don't Give the Same Number 00:14:30 Clinical Thresholds, Ethnic Adjustments, and the Waist-to-Height Ratio 00:15:45 The Weight-to-Waist Ratio: Tracking the Quality of Your Fat Loss 00:19:20 Sleep, Cortisol, and Why the Hormonal Environment Has to Support the Work 00:21:24 Why Exercise Reduces Visceral Fat 6× More Than Diet Alone 00:22:02 Mechanism 1 — Beta-3 Adrenergic Receptors and Preferential Visceral Fat Mobilization 00:24:10 Mechanism 2 — Myokines: The Fat-Burning Signal Only Contracting Muscle Can Send 00:26:21 GLP-1 Agonists and Body Composition: What the Clinical Trials Actually Show 00:28:05 DXA's Blind Spot: Myosteatosis, Glycogen, and Why Lean Mass Numbers Are Inflated 00:30:10 SEMALEAN, the BELIEVE Trial, and the 1-in-10 Reality of Long-Term Lifestyle Programs 00:33:15 Testosterone, Visceral Fat, and the Aromatase Feed-Forward Loop 00:36:05 Three Testosterone Ranges: Deficient, Eugonadal, and Supraphysiological 00:38:05 The Bhasin 4-Group Study — and Why AAS Are a Class, Not a Synonym for TRT 00:39:33 Tesamorelin: The GHRH Analogue That Selectively Targets Visceral Fat 00:40:53 Practical Framework: What to Measure, When, and What to Do 00:43:20 Key TakeawaysNext StepsFor evidence-based resistance training programs: barbellmedicine.com/training-programsFor individualized training consultation: barbellmedicine.com/coachingExplore our full library of articles on health and performance: barbellmedicine.com/resourcesTo join Barbell Medicine Plus and get ad-free listening, product discounts, exclusive content, and more: https://barbellmedicine.supercast.com/To consult with Drs. Baraki or Feigenbaum email us at support@barbellmedicine.com Barbell Medicine Vital 5 Action Plan: https://www.barbellmedicine.com/vital-5-action-plan/Resources:https://pubmed.ncbi.nlm.nih.gov/11502820/https://pubmed.ncbi.nlm.nih.gov/33567185/https://pubmed.ncbi.nlm.nih.gov/35658024/https://pubmed.ncbi.nlm.nih.gov/40318682/https://pubmed.ncbi.nlm.nih.gov/41068996/https://pubmed.ncbi.nlm.nih.gov/41772149/https://pubmed.ncbi.nlm.nih.gov/23944298/https://pubmed.ncbi.nlm.nih.gov/20948519/https://pubmed.ncbi.nlm.nih.gov/27213481/https://pubmed.ncbi.nlm.nih.gov/23303913/Our Sponsors:* Check out Factor: https://factormeals.com/bbm50off* Check out Quince: https://quince.com/BBMSupport this podcast at — https://redcircle.com/barbell-medicine-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode #389: Your Liver Enzymes Are Elevated — But It Might Not Be Your Liver

A fit, healthy 39-year-old was nearly sent for a liver biopsy. The cause? Was it that he went to the gym before every blood draw or because his supplement was throwing his labs off?. Dr. Jordan Feigenbaum and Dr. Austin Baraki break down the blind spot that sends thousands of healthy athletes down an expensive, potentially unnecessary diagnostic rabbit hole every year.Timestamps:00:01:09  Introducing the Case00:03:44  How to Read a Liver Panel: ALT, AST, GGT, Alk Phos, Albumin Explained00:10:50  What Is GGT and Why Does It Matter Clinically?00:16:38  Why Exercise, Protein, and Creatine Aren't on the Differential (Yet)00:17:35  The Workup: Hepatitis Panels, Abdominal Ultrasound, and More00:19:42  Second Set of Labs — The Mystery Deepens00:25:25  Updated Differential: What's Still on the List?00:27:08  The Labs Normalize — A Critical Clue Appears00:31:40  The Reveal: Exercise Was the Cause All Along00:32:18  The Mechanism: How Exercise Elevates 'Liver' Enzymes00:32:54  Point 1 — ALT & AST Are Not Exclusively Liver Enzymes00:33:49  Point 2 — It's Unavoidable: 100% of Lifters Are Affected00:36:02  Point 3 — It Takes 10–12 Days to Normalize00:37:00  Point 4 — It's Mostly Harmless00:38:27  56% of Physicians Miss This Diagnosis00:38:48  Why Clinicians Overlook Exercise History00:44:01  Point 5 — GGT as the Differentiator (And Its Limits)00:46:42  Why Alkaline Phosphatase Also Rises Post-Workout00:48:51  The Cost of Missing Lifestyle Context: Over- and Under-Diagnosis00:53:29  What to Say to Your Doctor: 3 Patient Scripts00:59:31  5 Key Takeaways01:00:25  Final Advice from Dr. Baraki Next StepsFor evidence-based resistance training programs: barbellmedicine.com/training-programsFor individualized training consultation: barbellmedicine.com/coachingExplore our full library of articles on health and performance: barbellmedicine.com/resourcesTo join Barbell Medicine Plus and get ad-free listening, product discounts, exclusive content, and more: https://barbellmedicine.supercast.com/To consult with Drs. Baraki or Feigenbaum email us at support@barbellmedicine.com Barbell Medicine Vital 5 Action Plan: https://www.barbellmedicine.com/vital-5-action-plan/Resources:Case: https://pubmed.ncbi.nlm.nih.gov/37025214/https://pubmed.ncbi.nlm.nih.gov/29059178/ https://pmc.ncbi.nlm.nih.gov/articles/PMC7438350/https://pubmed.ncbi.nlm.nih.gov/18557801/https://pubmed.ncbi.nlm.nih.gov/19209234/https://pubmed.ncbi.nlm.nih.gov/11476029/https://pmc.ncbi.nlm.nih.gov/articles/PMC11165564/https://pmc.ncbi.nlm.nih.gov/articles/PMC12460594/ https://pmc.ncbi.nlm.nih.gov/articles/PMC2291230/https://pmc.ncbi.nlm.nih.gov/articles/PMC11319523/ https://pmc.ncbi.nlm.nih.gov/articles/PMC3936967/https://pmc.ncbi.nlm.nih.gov/articles/PMC12188904/https://pmc.ncbi.nlm.nih.gov/articles/PMC7969109/https://pmc.ncbi.nlm.nih.gov/articles/PMC11498664/https://pmc.ncbi.nlm.nih.gov/articles/PMC3104191/Our Sponsors:* Check out Factor: https://factormeals.com/bbm50off* Check out Quince: https://quince.com/BBMSupport this podcast at — https://redcircle.com/barbell-medicine-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode #388: Muscle Imbalances, Red Meat Risk, and the Science of Body Fat Set Points

In this special preview of the Barbell Medicine Plus Direct Line, Dr. Jordan Feigenbaum and Dr. Austin Baraki move past the fitness basics to tackle high-level technical nuances. We dive into the persistent myth of "muscle imbalances" and why your asymmetry might actually be a functional feature of your training.We also address the "meat" of the cardiovascular debate: is red meat and saturated fat consumption still risky if you are highly active and have a high-fiber diet? Finally, we explore the Dual Intervention Point Model to explain why the body defends its energy stores and how our environment has shifted the biological "set point" for body fat.Timestamps00:00 – Barbell Medicine Plus: Special Annual Membership Promotion01:03 – Muscle Imbalances: A Reliable Predictor of Pain?03:59 – Acuted vs. Gradually Acquired Asymmetries08:55 – How Coaches Should Manage "Alignment" Beliefs11:54 – Is Red Meat Necessary to Limit if You Are Otherwise Healthy?15:36 – The Role of Substitution: Plant vs. Animal Protein19:50 – Analyzing the Lean Mass Hyper-Responder (LMHR) Phenotype26:20 – The Dual Intervention Point Model of Body Fatness30:26 – Lipostat, Gravistat, and the Regulation of Energy StoresNext StepsFor evidence-based resistance training programs: barbellmedicine.com/training-programsFor individualized training consultation: barbellmedicine.com/coachingExplore our full library of articles on health and performance: barbellmedicine.com/resourcesTo join Barbell Medicine Plus and get ad-free listening, product discounts, exclusive content, and more: https://barbellmedicine.supercast.com/To consult with Drs. Baraki or Feigenbaum email us at support@barbellmedicine.com Barbell Medicine Vital 5 Action Plan: https://www.barbellmedicine.com/vital-5-action-plan/ Key TakeawaysAsymmetry as a Feature: Human bodies are not naturally symmetrical. In many athletes—such as tennis players, pitchers, or rowers—asymmetry is a functional adaptation to the sport's demands.The Pathological vs. The Normal: Acutely acquired asymmetries (post-surgery or trauma) require specific clinical attention. Long-standing or gradually acquired asymmetries are rarely the primary driver of pain.Saturated Fat & The Healthy User Bias: While fit individuals have a lower overall risk profile, elevated LDL and ApoB particles represent a "time-volume" exposure risk that should not be ignored based solely on lifestyle.The Lean Mass Hyper-Responder (LMHR): We analyze the bold claims surrounding the LMHR phenotype and discuss why mechanistic hypothesizing currently lacks the "hard human outcome receipts" to prove long-term safety.Body Fat Regulation: The Dual Intervention Point Model suggests the body defends a lower boundary (starvation) and an upper boundary (predation). In the modern environment, the "predation pressure" has vanished, leading to a genetic drift upward in body fat set points.Our Sponsors:* Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com* Check out Factor: https://factormeals.com/bbm50off* Check out Quince: https://quince.com/BBMSupport this podcast at — https://redcircle.com/barbell-medicine-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy